Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Network Trial
Titel:
Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Network Trial
Auteur:
Litzow, Mark R. Sun, Zhuoxin Paietta, Elisabeth Mattison, Ryan J. Lazarus, Hillard M Rowe, Jacob M. Arber, Daniel A. Mullighan, Charles G. Willman, Cheryl L Zhang, Yanming Wieduwilt, Matthew Liedtke, Michaela Bergeron, Julie Pratz, Keith W. Dinner, Shira Frey, Noelle V. Gore, Steven D. Bhatnagar, Bhavana Atallah, Ehab L. Uy, Geoffrey L. Jeyakumar, Deepa Lin, Tara L. Little, Richard F. Luger, Selina M. Tallman, Martin S.